The corporate AI landscape is undergoing a massive cultural evolution, moving past experimental hype and into an era of ruthless hyper-efficiency. According to a new CNBC report, corporate buyers have entered a phase dubbed "Valuemaxxing," where they are demanding measurable, workflow-integrated results for every dollar spent. Meanwhile, on the frontier of medicine, Stanford researchers have unveiled Biomni, an AI "Co-Scientist" capable of compressing months of manual biological data cleaning and laboratory legwork into mere minutes.

We’ll talk about:

• The enterprise shift to "Valuemaxxing," where "almost unlimited" corporate demand for AI infrastructure is colliding with real-world energy and power grid bottlenecks.
• Stanford debuting Biomni, a biomedical powerhouse packed with 150 specialized tools ...